Cancer Risks in Patients with Insulin-Treated Diabetes
Author Information
Author(s): A J Swerdlow, S P Laing, Z Qiao, S D Slater, A C Burden, J L Botha, N R Waugh, A D Morris, W Gatling, E A Gale, C C Patterson, H Keen
Primary Institution: Institute of Cancer Research
Hypothesis
What is the cancer risk in patients with type I diabetes compared to those with type II diabetes?
Conclusion
Patients with insulin-treated diabetes diagnosed under age 30 have a significantly raised risk of ovarian cancer, while other cancer risks are not substantially increased.
Supporting Evidence
- The study followed 28,900 patients for a total of 520,517 person-years.
- Ovarian cancer risk was significantly raised in patients diagnosed with diabetes under age 30.
- No substantial increase in cancer risk was found for other major sites in type I diabetes patients.
Takeaway
This study found that young people with diabetes are more likely to get ovarian cancer, but not other types of cancer.
Methodology
A cohort study of 28,900 UK patients with insulin-treated diabetes was conducted, comparing their cancer incidence and mortality with national expectations over 520,517 person-years.
Potential Biases
Potential confounding factors such as obesity and alcohol consumption were not fully accounted for.
Limitations
The study lacked individual data on menstrual or reproductive factors and did not analyze nonmelanoma skin cancer due to incomplete registration.
Participant Demographics
The cohort consisted of 28,900 patients, with 15,688 males and 13,212 females, most diagnosed under age 30.
Statistical Information
P-Value
0.005
Confidence Interval
95% CI 1.22–3.48
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website